Endocrine imaging encompasses anatomical and functional imaging techniques used to evaluate endocrine glands and hormone-producing tissues. Ultrasound, CT, MRI, nuclear medicine, and specialized functional studies help characterize lesions of the thyroid, parathyroid glands, pituitary gland, adrenal glands, pancreas, and other endocrine structures.
Endocrine imaging refers to the use of anatomical and functional imaging techniques to evaluate endocrine glands, hormone-producing tissues, and lesions affecting endocrine function. Because endocrine organs are distributed throughout the body and vary considerably in size, location, composition, and physiological activity, no single imaging modality is optimal for every endocrine structure.
Common techniques include ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), and nuclear medicine imaging. These modalities provide different types of information. Ultrasound, CT, and MRI primarily demonstrate anatomy and structural abnormalities, while nuclear medicine techniques can provide information about tissue function, receptor expression, or metabolic activity.
Imaging is generally interpreted together with clinical findings and biochemical endocrine testing. A structural abnormality does not necessarily indicate abnormal hormone production, and a hormonally active lesion can sometimes be very small. Understanding both endocrine anatomy and physiology is therefore essential when interpreting imaging findings.
Endocrine imaging can be used to identify, localize, characterize, and monitor abnormalities of endocrine organs.
Major applications include:
Endocrine imaging can broadly be divided into structural imaging and functional imaging.
| Imaging Type | Primary Information | Examples |
|---|---|---|
| Structural imaging | Anatomy, morphology, size, composition and relationships | Ultrasound, CT, MRI |
| Functional imaging | Physiological activity, tracer uptake or receptor expression | Scintigraphy, SPECT, PET |
Ultrasound uses high-frequency sound waves to create real-time images of tissues.
It is particularly valuable for superficial endocrine structures because it provides high spatial resolution without ionizing radiation.
Ultrasound is less effective for structures located deep within the body or behind bone or gas-containing organs.
Image quality and interpretation can also depend substantially on the operator, equipment, and patient anatomy.
Ultrasound is a major structural imaging modality for the thyroid gland.
The thyroid's superficial position in the anterior neck allows detailed visualization of its lobes, isthmus, parenchyma, nodules, and relationships to nearby structures.
Normal thyroid parenchyma generally demonstrates relatively homogeneous echogenicity.
Ultrasound allows measurement of thyroid dimensions and evaluation for focal or diffuse abnormalities.
A thyroid nodule is a discrete lesion within the thyroid gland that is radiologically distinguishable from surrounding thyroid tissue.
Ultrasound can characterize features including:
Ultrasound can distinguish fluid-containing structures from solid tissue and can identify nodules containing both solid and cystic components.
This distinction contributes to structural characterization of thyroid lesions.
Doppler ultrasound evaluates movement of blood within vessels and tissue vascularity.
It can provide supplementary information about blood flow within endocrine organs and lesions.
Ultrasound can guide fine-needle aspiration of selected thyroid nodules or cervical lymph nodes.
Real-time visualization allows accurate placement of the needle within the target while helping avoid adjacent structures.
Normal parathyroid glands are usually too small to be reliably identified on routine ultrasound.
Enlarged abnormal parathyroid glands can sometimes be visualized, particularly when located near their expected cervical positions.
Imaging of hyperfunctioning parathyroid tissue is primarily used for localization before surgery rather than for establishing the biochemical diagnosis of hyperparathyroidism.
Ultrasound may be combined with functional nuclear medicine studies or other cross-sectional imaging techniques.
Computed tomography (CT) uses X-rays and computer reconstruction to produce cross-sectional images of the body.
CT provides excellent spatial resolution and is particularly useful for evaluating deep endocrine structures and their relationships to surrounding tissues.
CT characterizes tissues partly according to their attenuation of X-rays, commonly expressed in Hounsfield units (HU).
Differences in attenuation can help characterize tissue composition.
Intravenous iodinated contrast material can improve visualization of blood vessels and patterns of tissue enhancement.
Enhancement characteristics can provide useful information about endocrine lesions and surrounding anatomy.
CT is widely used for structural evaluation of the adrenal glands.
The adrenal glands are retroperitoneal structures positioned superior and medial to the kidneys. Their deep location makes cross-sectional imaging particularly valuable.
Adrenal lesions can be evaluated according to size, attenuation, homogeneity, enhancement pattern, calcification, fat content, and relationships to surrounding structures.
Imaging findings are interpreted together with biochemical evaluation because structural appearance alone does not establish whether an adrenal lesion is hormonally active.
Many adrenal cortical adenomas contain abundant intracellular lipid.
This characteristic can produce relatively low attenuation on unenhanced CT and can assist in differentiating many lipid-rich adenomas from other adrenal masses.
Contrast-enhanced CT protocols can evaluate the pattern by which contrast material enters and subsequently leaves an adrenal lesion.
Calculated contrast washout characteristics can provide additional information when characterizing selected adrenal masses.
CT is sensitive for detecting calcification within the adrenal glands.
Adrenal calcification can occur after hemorrhage, infection, or other pathological processes and must be interpreted within the broader clinical context.
Acute adrenal hemorrhage can alter adrenal size and attenuation on CT.
Imaging is particularly important when bilateral adrenal involvement is suspected because extensive bilateral injury can impair adrenal cortical function.
CT can evaluate the pancreas and lesions arising from its endocrine component.
Cross-sectional imaging provides information about lesion location, vascular relationships, regional lymph nodes, and distant disease.
Pancreatic neuroendocrine tumors arise from neuroendocrine cells and can be functional or nonfunctional.
Many demonstrate prominent enhancement because of their vascularity, making appropriately timed contrast-enhanced imaging useful for detection and characterization.
Magnetic resonance imaging (MRI) uses magnetic fields and radiofrequency signals to produce detailed images without ionizing radiation.
MRI provides excellent soft-tissue contrast and is particularly important for evaluation of the pituitary gland, hypothalamic region, adrenal glands, and selected pancreatic or pelvic endocrine abnormalities.
MRI appearance depends on tissue composition and the imaging sequence used.
Common sequences include T1-weighted and T2-weighted imaging, while additional techniques can assess enhancement, diffusion, fat content, and other tissue characteristics.
Gadolinium-based contrast agents can be used in selected MRI examinations to evaluate patterns of tissue enhancement.
Contrast enhancement is particularly useful in evaluation of small lesions within complex soft-tissue structures such as the pituitary gland.
MRI is the principal imaging technique for detailed structural evaluation of the pituitary gland and sellar region.
The pituitary lies within the sella turcica of the sphenoid bone and is closely related to the optic chiasm, cavernous sinuses, internal carotid arteries, hypothalamus, and sphenoid sinus.
| Relationship | Structure |
|---|---|
| Superior | Optic chiasm and hypothalamic region |
| Lateral | Cavernous sinuses and internal carotid arteries |
| Inferior | Sphenoid sinus |
| Posterior | Dorsum sellae and posterior sellar structures |
Pituitary adenomas are benign neoplasms arising from adenohypophyseal cells and may be associated with excessive secretion of pituitary hormones.
MRI can demonstrate the lesion itself and assess its relationship to surrounding structures.
Small pituitary adenomas can be difficult to distinguish from normal pituitary tissue.
High-resolution MRI and contrast-enhanced techniques can improve detection of subtle lesions.
Larger pituitary tumors can expand the sella and extend into adjacent anatomical compartments.
MRI can assess suprasellar extension, compression of the optic apparatus, and lateral extension toward the cavernous sinuses.
The close superior relationship between the pituitary gland and the optic chiasm is clinically important.
An enlarging sellar mass can compress the optic pathways and produce characteristic visual field abnormalities.
MRI also allows visualization of the pituitary stalk, which connects the pituitary gland to the hypothalamus.
Stalk thickening, displacement, or interruption can provide important anatomical information in selected endocrine disorders.
The posterior pituitary can demonstrate characteristic signal properties on MRI.
Alterations in posterior pituitary appearance must be interpreted together with the clinical and endocrine findings.
MRI can characterize adrenal lesions without ionizing radiation and can provide information complementary to CT.
It is particularly useful when tissue composition or vascular relationships require further evaluation.
Chemical shift MRI exploits differences in resonance between fat and water molecules.
Many lipid-rich adrenal adenomas demonstrate signal loss on opposed-phase imaging because of intracellular lipid, helping distinguish them from many nonadenomatous lesions.
Pheochromocytomas are catecholamine-producing tumors that usually arise from chromaffin cells of the adrenal medulla.
CT and MRI can localize adrenal masses after biochemical evidence suggests catecholamine excess. Functional imaging can be useful in selected cases, particularly when multifocal, metastatic, recurrent, or extra-adrenal disease is suspected.
Nuclear medicine uses radiopharmaceuticals that accumulate within tissues according to specific physiological, metabolic, or receptor-related properties.
This allows imaging to provide functional information that may not be apparent from anatomy alone.
Scintigraphy detects gamma radiation emitted by administered radiopharmaceuticals.
The resulting distribution of tracer can demonstrate patterns of endocrine tissue function.
Single-photon emission computed tomography (SPECT) reconstructs three-dimensional images from gamma-emitting radiotracers.
SPECT can be combined with CT to provide both functional and anatomical localization.
Positron emission tomography (PET) detects pairs of photons produced following positron-emitting radionuclide decay.
PET is frequently combined with CT or MRI so that functional tracer uptake can be localized anatomically.
Thyroid scintigraphy evaluates the functional distribution of tracer uptake within thyroid tissue.
It can provide information about whether portions of the thyroid are functioning autonomously, normally, or relatively poorly.
The thyroid actively concentrates iodide for thyroid hormone synthesis.
This physiological property allows radioactive iodine isotopes to be used for functional assessment of thyroid tissue.
Technetium-based radiopharmaceuticals can also be used for thyroid scintigraphy because selected tracers are taken up by thyroid follicular cells through pathways related to iodide transport.
A hyperfunctioning or hot nodule demonstrates increased tracer uptake relative to surrounding thyroid tissue.
This indicates increased functional activity within the nodule.
A hypofunctioning or cold nodule demonstrates reduced tracer uptake relative to surrounding thyroid tissue.
This is a functional description and does not by itself establish the histological nature of the lesion.
| Feature | Ultrasound | Scintigraphy |
|---|---|---|
| Primary information | Structure and morphology | Functional tracer uptake |
| Nodule composition | Can characterize solid and cystic components | Limited structural characterization |
| Functional activity | Not directly measured | Demonstrated through tracer uptake |
| Ionizing radiation | No | Yes |
Nuclear medicine techniques can help localize hyperfunctioning parathyroid tissue before surgery.
Radiopharmaceutical localization is often combined with anatomical imaging to improve spatial precision.
Technetium-99m sestamibi is commonly used for parathyroid localization.
Abnormal parathyroid tissue can retain the tracer differently from surrounding thyroid tissue, allowing localization in appropriate clinical settings.
Combining SPECT with CT provides functional tracer information together with cross-sectional anatomical localization.
This can be particularly useful when abnormal parathyroid tissue lies in an ectopic or otherwise difficult anatomical position.
Parathyroid glands demonstrate considerable anatomical variation because of their embryological migration.
Ectopic glands can occur in cervical or mediastinal locations, making accurate preoperative localization valuable in selected patients.
Some neuroendocrine tumors express high levels of specific cell-surface receptors that can be targeted with radiolabeled molecules.
This provides a method for detecting lesions based on their molecular characteristics rather than anatomy alone.
Many well-differentiated neuroendocrine tumors express somatostatin receptors.
Radiolabeled somatostatin analogues can bind to these receptors and permit functional imaging of primary and metastatic lesions.
PET radiopharmaceuticals targeting somatostatin receptors can provide sensitive whole-body imaging of appropriately receptor-positive neuroendocrine tumors.
The PET component identifies receptor-related tracer uptake, while accompanying CT or MRI provides anatomical localization.
An endocrine tumor is described as functional when it produces hormones in quantities sufficient to cause a recognizable clinical syndrome.
A nonfunctional tumor does not produce a clinically apparent hormone excess syndrome, although it may still express endocrine markers or receptors.
Imaging and biochemical testing answer different questions and are frequently complementary.
| Assessment | Primary Question |
|---|---|
| Hormone measurement | Is endocrine secretion abnormal? |
| Structural imaging | Is there an anatomical lesion, and where is it? |
| Functional imaging | Does tissue demonstrate a particular physiological or molecular activity? |
Modern cross-sectional imaging frequently detects endocrine abnormalities incidentally during studies performed for unrelated reasons.
Examples include thyroid nodules, adrenal masses, pituitary lesions, and pancreatic abnormalities.
An adrenal incidentaloma is an adrenal mass discovered unexpectedly during imaging performed for another reason.
Evaluation generally considers two major questions: whether the lesion has concerning structural characteristics and whether it demonstrates clinically significant hormone secretion.
A pituitary incidentaloma is a previously unsuspected sellar lesion detected during imaging performed for another indication.
Its significance depends on lesion size, endocrine activity, and relationships to nearby structures such as the optic apparatus.
Thyroid nodules are frequently detected incidentally on CT, MRI, PET, or vascular imaging of the neck and chest.
Dedicated thyroid ultrasound can provide more detailed structural characterization when further evaluation is indicated.
Imaging can guide diagnostic and therapeutic procedures involving endocrine structures.
Ultrasound and CT are particularly useful for real-time or spatial guidance of needles and other instruments.
Fine-needle aspiration obtains cells from a target lesion for cytological examination.
It is commonly performed under ultrasound guidance for selected thyroid nodules and suspicious cervical lymph nodes.
CT and MRI display endocrine organs in cross-sectional planes and therefore require an understanding of surrounding anatomical landmarks.
This is particularly important for small structures such as the adrenal glands, pituitary gland, parathyroid glands, and pancreatic neuroendocrine lesions.
Modern CT and MRI datasets can be evaluated in multiple anatomical planes.
Coronal and sagittal views complement axial imaging and can clarify relationships between endocrine lesions and adjacent structures.
| Modality | Major Strength | Common Endocrine Applications |
|---|---|---|
| Ultrasound | High-resolution superficial imaging | Thyroid, cervical parathyroid localization, image-guided procedures |
| CT | Fast cross-sectional anatomical imaging | Adrenal glands, pancreas, deep neck and staging |
| MRI | Excellent soft-tissue contrast | Pituitary, hypothalamus, adrenal characterization and selected pancreatic lesions |
| Scintigraphy/SPECT | Functional tracer distribution | Thyroid and parathyroid functional localization |
| PET | Molecular and metabolic whole-body imaging | Selected neuroendocrine tumors and oncological assessment |
| Technique | Major Role |
|---|---|
| Ultrasound | Structural assessment of gland and nodules |
| Doppler ultrasound | Assessment of vascularity |
| Scintigraphy | Functional assessment of tracer uptake |
| CT/MRI | Assessment of selected large, invasive, retrosternal, or anatomically complex disease |
| Technique | Major Role |
|---|---|
| MRI | Primary detailed structural evaluation of pituitary and sellar region |
| Contrast-enhanced MRI | Improved characterization and detection of selected lesions |
| CT | Useful for selected bony or calcified sellar abnormalities and when MRI is unsuitable |
| Technique | Major Role |
|---|---|
| Unenhanced CT | Attenuation and structural characterization |
| Contrast-enhanced CT | Enhancement, washout and anatomical relationships |
| MRI | Tissue characterization and alternative cross-sectional evaluation |
| Chemical shift MRI | Detection of intracellular lipid in many adrenal adenomas |
| Functional imaging | Selected adrenal tumors and metastatic evaluation |
CT, scintigraphy, SPECT, and PET involve exposure to ionizing radiation, while ultrasound and MRI do not.
The choice of imaging modality considers diagnostic benefit, patient characteristics, the anatomical question being investigated, and radiation exposure.
Some endocrine imaging examinations use intravenous contrast agents to improve tissue characterization.
CT commonly uses iodinated contrast material, while MRI commonly uses gadolinium-based contrast agents. Their use depends on the clinical question and individual patient factors.
Endocrine glands can appear structurally abnormal while functioning normally, and small lesions can produce substantial hormonal abnormalities despite limited anatomical change.
For this reason, endocrine imaging is frequently most informative when performed in the context of appropriate biochemical evaluation.
| Feature | Key Point |
|---|---|
| Ultrasound | Particularly useful for superficial endocrine structures such as the thyroid |
| CT | Provides detailed cross-sectional anatomy and is widely used for adrenal evaluation |
| MRI | Provides excellent soft-tissue contrast and is central to pituitary imaging |
| Scintigraphy | Demonstrates functional radiotracer distribution |
| SPECT | Provides three-dimensional functional imaging and can be combined with CT |
| PET | Provides sensitive molecular or metabolic imaging using positron-emitting tracers |
| Thyroid ultrasound | Characterizes thyroid structure and nodules |
| Pituitary MRI | Evaluates the pituitary gland and surrounding sellar structures |
| Adrenal CT/MRI | Characterizes adrenal masses and their anatomical relationships |
| Parathyroid imaging | Primarily localizes abnormal glands after biochemical diagnosis |
Endocrine imaging demonstrates the importance of combining structural anatomy with physiological information. Endocrine glands range from the superficial thyroid gland in the neck to the small pituitary gland within the skull and the deeply situated adrenal glands in the retroperitoneum. Their differing locations and tissue characteristics explain why different imaging techniques are preferred for different organs.
Structural imaging identifies the size, shape, composition, and anatomical relationships of endocrine tissues. Functional imaging provides another dimension by demonstrating physiological activity, radiotracer uptake, or receptor expression. These approaches can complement one another when an endocrine lesion must be localized or characterized.
Imaging findings must also be interpreted alongside hormone measurements. A small pituitary or pancreatic lesion can produce major endocrine abnormalities, while a comparatively large adrenal or thyroid lesion may be hormonally inactive. Endocrine diagnosis therefore depends on integrating anatomy, imaging, physiology, and biochemical testing rather than relying on structural appearance alone.